NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.70+0.02 (+0.30%)
Close on Nov 17, 2026Market cap $30.67MP/E –Yield 0.00%
NextCure price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NextCure's price to book ratio was 2.0× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.2× to 2.1×, with a median of 0.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | +0.4 |
| 2025 | Dec 31, 2025 | 1.6× | +1.3 |
| 2024 | Dec 31, 2024 | 0.3× | +0.0 |
| 2023 | Dec 29, 2023 | 0.3× | +0.0 |
| 2022 | Dec 30, 2022 | 0.2× | −0.5 |
| 2021 | Dec 31, 2021 | 0.7× | −0.3 |
| 2020 | Dec 31, 2020 | 1.0× | −6.5 |
| 2019 | Dec 31, 2019 | 7.5× | – |
See a number that looks wrong?